Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hixson Architecture, Engineering, Interiors | Contract Pharma

What are you searching for?

Sign in

Search by

Hixson Architecture, Engineering, Interiors

Company Headquarters

659 Van Meter Street , Suite 300, Cincinnati, OH, 45202, US

Driving Directions Phone: View Phone
View website

Request more information from Hixson Architecture, Engineering, Interiors

Request more information from Hixson Architecture, Engineering, Interiors

Categories from Hixson Architecture, Engineering, Interiors

Architectural Services
Engineering and Design Services
Facility Design
Facility Planning
Feasibility Studies

Related Content

Breaking News

AustinPx KinetiSol Earns FDA AMT Designation

Solvent-free technology expands manufacturing options for poorly soluble oral drug candidates.

By: Charlie Sternberg

Breaking News

WuXi XDC Secures GMP Release for Singapore Manufacturing Site

The designation applies to the site’s BCM3 antibody intermediate and conjugated drug substance dual-function production line, and DP4 facility.

By: Patrick Lavery

Online Exclusives

Addressing Barriers to Access for Today’s Cell and Gene Therapies

Decisions around trial design, regulatory strategy, and manufacturing planning ultimately determine whether a therapy reaches patients.

By: Kristin Brooks

Breaking News

Thermo Fisher Launches SuperScript V Reverse Transcriptase

Next-gen engineered enzyme designed to make the critical step of converting RNA to cDNA faster.

By: Charlie Sternberg

Trials & Filings

T-Maximum Gains FDA Fast Track Status for CAR-T Glioblastoma Therapy

MT027 previously received Orphan Drug Designation, and T-Maximum was authorized to start a Phase II study.

By: Patrick Lavery

Expert’s Opinion

Design-Led Cleanrooms: How Risk-Based Digital Strategies are Reshaping Pharma

QbD, digital platforms, and risk-based, paperless validation approaches can dramatically accelerate project delivery, reduce inspection findings, and improve documentation efficiency.

By: Sachin Maled

Collaborations & Alliances

miRecule, Rio Biofarma Brasil to Co-Develop Peptide Tech for Targeted RNA Delivery

miRecule’s proprietary precision RNA design platform is combining with RBBL’s expertise in peptide discovery, development, and manufacturing.

By: Patrick Lavery

Trials & Filings

FDA Approves NSCLC Treatment Acquired by GSK in Nuvalent Deal

Jideytro, a ROS1 selective inhibitor, previously received Breakthrough Therapy and Orphan Drug designations.

By: Patrick Lavery

Promotions & Moves

Biohaven Announces Scientific Leadership Changes

Davird Pirman promoted to EVP and Head of Discovery; Bruce Car transitions to Chief Innovation Officer; Warren Volles designated Executive Officer.

By: Charlie Sternberg

Trials & Filings

WuXi Biologics Drug Substance Manufacturing Facility Passes FDA Pre-License Inspection

The designation supports commercial manufacturing for a potential blockbuster autoimmune therapy.

By: Patrick Lavery

Breaking News

Evotec Makes Continuous Manufacturing Technology Available on a Turnkey Basis

J.TRAIN is designed to enable biopharma companies to increase capacity and manufacture biologics at reduced costs and improved productivity.

By: Charlie Sternberg

Collaborations & Alliances

Natera, Aveta Biomics Ink Partnership to Support Phase III Trial in Head and Neck Cancer

Aveta’s first-in-class immunotherapy has U.S. FDA Fast Track and Orphan Drug designations.

By: Patrick Lavery

Expert’s Opinion

From Potential to Practical at DIA 2026: A Three-Part Series on Unlocking AI’s Role in Modern Clinical Trials

Reimagining trial design from static protocols to predictive simulation.

By: Raja Shankar

Breaking News

Single Use Support Unveils RoSS.BLST Next-Gen Blast Freezer

The freezing and thawing platform is designed for maximizing process consistency and product quality for high-value biologics.

By: Patrick Lavery

Collaborations & Alliances

Merck Taps Protillion for AI Protein Design

Collaboration will use Protillion’s protein design AI platform to discover novel therapeutic candidates.

By: Charlie Sternberg